Related Experiment Videos

Vulnerable atherosclerotic plaque: emerging challenge for animal models

Mark Rekhter1

  • 1Department of Cardiovascular Pharmacology, Pfizer Global Research and Development, 2800 Plymouth Road, Ann Arbor, MI 48105, USA. mark.rekhter@pfizer.com

Summary

Developing better animal models for plaque vulnerability is crucial for acute coronary syndromes. This review discusses current models and challenges, highlighting the need for plaque-stabilizing therapies.

Related Concept Videos